Cargando…
Progress in the clinical application of immune checkpoint inhibitors in small cell lung cancer
Small cell lung cancer (SCLC) is a refractory cancer with poor prognosis due to its aggressive malignancy and high rates of metastasis, recurrence and drug resistance. These characteristics have also greatly impeded the identification of new treatment methods and drugs. The traditional model of SCLC...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Frontiers Media S.A.
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10090448/ https://www.ncbi.nlm.nih.gov/pubmed/37063927 http://dx.doi.org/10.3389/fimmu.2023.1126582 |